Journal Home > Volume 11 , Issue 3

The role of gut microbiota in terms of host health is becoming increasingly important. In this study, the comparative effects of tea polyphenols (TPs) on weight loss and lipid metabolism on conventionalized mice (CVZ) and pseudo germ-free (PGF) mice (treated with antibiotics) were investigated. Our findings revealed that high fat (HF) diet considerably increased the body weight, total fat and upsurge lipid indices in CVZ mice but PGF mice were not sensitive to the effect of HF diet as CVZ mice. After the dietary administration of TP, body weight, perirenal fat and epididymal fat, liver weight, glucose (GLU) level, total chloestrol (TC level), high density lipoprotein-cholesterol (HDL-C) level significantly lowered in PGF mice as compared to CVZ mice group. However, the area of fat cells and triglyceride (TG) level were significantly increased in PGF mice. In CVZ mice, TP intervention resulted in a considerable drop in the Firmicutes/Bacteroides ratio as compared to PGF mice. The intestinal flora of PGF mice was severely reduced after antibiotic treatment, while TP administration restored intestinal diversity; the abundance of Akkermansia and Lactobacillus increased, whereas the abundance of Enterobacteriaceae and Prevotella reduced. Overall, we can assume that PGF obese mice administered with TP have less anti-obesity effects compared to obese CVZ mice.


menu
Abstract
Full text
Outline
About this article

Comparative study on the weight loss and lipid metabolism by tea polyphenols in diet induced obese C57BL/6J pseudo germ free and conventionalized mice

Show Author's information Kashif Hussaina,1Yingying Yanga,b,1Jie Wanga,1Hengjuan BianaXi LeiaJunjie ChenaQianying LiaLi WangaQingping ZhongaXiang FangaYutao WangcHong WeidYigang TongeZhenlin Liaoa,c( )
College of Food Science, South China Agricultural University, Guangzhou 510642, China
Department of Food Science, University of Guelph, Guelph, Ontario N1G 2W1, Canada
College of Life and Geographic Sciences, Key Laboratory of Biological Resources and Ecology of Pamirs Plateau in Xinjiang Uygur Autonomous Region, Kashi University, Kashi 844000, China
Institute of Precision Medicine, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China
College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China

1 The authors contributed equally to this article.

Peer review under responsibility of KeAi Communications Co., Ltd.

Abstract

The role of gut microbiota in terms of host health is becoming increasingly important. In this study, the comparative effects of tea polyphenols (TPs) on weight loss and lipid metabolism on conventionalized mice (CVZ) and pseudo germ-free (PGF) mice (treated with antibiotics) were investigated. Our findings revealed that high fat (HF) diet considerably increased the body weight, total fat and upsurge lipid indices in CVZ mice but PGF mice were not sensitive to the effect of HF diet as CVZ mice. After the dietary administration of TP, body weight, perirenal fat and epididymal fat, liver weight, glucose (GLU) level, total chloestrol (TC level), high density lipoprotein-cholesterol (HDL-C) level significantly lowered in PGF mice as compared to CVZ mice group. However, the area of fat cells and triglyceride (TG) level were significantly increased in PGF mice. In CVZ mice, TP intervention resulted in a considerable drop in the Firmicutes/Bacteroides ratio as compared to PGF mice. The intestinal flora of PGF mice was severely reduced after antibiotic treatment, while TP administration restored intestinal diversity; the abundance of Akkermansia and Lactobacillus increased, whereas the abundance of Enterobacteriaceae and Prevotella reduced. Overall, we can assume that PGF obese mice administered with TP have less anti-obesity effects compared to obese CVZ mice.

Keywords: Obesity, Lipid metabolism, High fat diet, Pseudo germ-free mice, Tea polyphenol

References(43)

[1]

F. Bäckhed, H. Ding, T. Wang, et al., The gut microbiota as an environmental factor that regulates fat storage, Proc. Natl. Acad. Sci. 101 (2004) 15718-15723. https://doi.org/10.1073/pnas.0407076101

[2]

R.E. Ley, C.A. Lozupone, M. Hamady, et al., Worlds within worlds: evolution of the vertebrate gut microbiota, Nat. Rev. Microbiol. 6 (2008) 776-788. https://doi.org/10.1038/nrmicro1978

[3]

B.E. Meyerson, M.A. Sayegh, State size and government level matter most: a structural equation model of local health department policy behaviors, J. Public Heal. Manag. Pract. 22 (2016) 157-163. https://doi.org/10.1097/PHH.0000000000000244

[4]

J.G.M. Markle, D.N. Frank, K. Adeli, et al., Microbiome manipulation modifies sex-specific risk for autoimmunity, Gut Microbes. 5 (2014) 485-493. ttps://doi.org/10.4161/gmic.29795

[5]

P.J. Turnbaugh, V.K. Ridaura, J.J. Faith, et al., The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice, Sci. Transl. Med. 1 (2009) 6ra14. https://doi.org/10.1126/scitranslmed.3000322

[6]

F. Bäckhed, R.E. Ley, J.L. Sonnenburg, et al., Host-bacterial mutualism in the human intestine, Science 307 (2005) 1915-1920. https://doi.org/10.1126/science.1104816

[7]

N. Suárez-Zamorano, S. Fabbiano, C. Chevalier, et al., Microbiota depletion promotes browning of white adipose tissue and reduces obesity, Nat. Med. 21 (2015) 1497-1501. https://doi.org/10.1038/nm.3994

[8]

H. Liu, B. Wu, G. Pan, et al., Metabolism and pharmacokinetics of mangiferin in conventional rats, pseudo-germ-free rats, and streptozotocin-induced diabetic rats, Drug Metab. Dispos. 40 (2012) 2109-2118. https://doi.org/10.1124/dmd.112.045849

[9]

I. Kimura, K. Ozawa, D. Inoue, et al., The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43, Nat. Commun. 4 (2013) 1829. https://doi.org/10.1038/ncomms2852

[10]

Z. Wang, E. Klipfell, B.J. Bennett, et al., Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease, Nature 472 (2011) 57-63. https://doi.org/10.1038/nature09922

[11]

T.B. Clarke, K.M. Davis, E.S. Lysenko, et al., Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity, Nat. Med. 16 (2010) 228-231. https://doi.org/10.1038/nm.2087

[12]

M. Grover, P.C. Kashyap, Germ-free mice as a model to study effect of gut microbiota on host physiology, Neurogastroenterol. Motil. 26 (2014) 745-748. https://doi.org/10.1111/nmo.12366

[13]

S.H. Lee, J.H. An, H.J. Lee, et al., Evaluation of pharmacokinetic differences of acetaminophen in pseudo germ free rats, Biopharm. Drug Dispos. 33 (2012) 292-303. https://doi.org/10.1002/bdd.1799

[14]

M. Ninomiya, L. Unten, M. Kim, Chemical and physicochemical properties of green tea polyphenols, Chem. Appl. Green Tea. (1997) 23-35

[15]

S. Wolfram, D. Raederstorff, Y. Wang, et al., TEAVIGOTM (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass, Ann. Nutr. Metab. 49 (2005) 54-63. https://doi.org/10.1159/000084178

[16]

S. Klaus, S. Pültz, C. Thöne-Reineke, et al., Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation, Int. J. Obes. 29 (2005) 615-623. https://doi.org/10.1038/sj.ijo.0802926

[17]

T. Nagao, T. Hase, I. Tokimitsu, A green tea extract high in catechins reduces body fat and cardiovascular risks in humans, Obesity 15 (2007) 1473-1483. https://doi.org/10.1038/oby.2007.176

[18]

C.H. Hsu, T.H. Tsai, Y.H. Kao, et al., Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial, Clin. Nutr. 27 (2008) 363-370. https://doi.org/10.1016/j.clnu.2008.03.007

[19]

M.S. Westerterp-Plantenga, Green tea catechins, caffeine and body-weight regulation, Physiol. Behav. 100 (2010) 42-46. https://doi.org/10.1016/j.physbeh.2010.02.005

[20]

D. Heber, Y. Zhang, J. Yang, et al., Green tea, black tea, and oolong tea polyphenols reduce visceral fat and inflammation in mice fed high-fat, high-sucrose obesogenic diets, J. Nutr. 144 (2014) 1385-1393. https://doi.org/10.3945/jn.114.191007

[21]

J. Huang, Y. Zhang, Y. Zhou, et al., Green tea polyphenols alleviate obesity in broiler chickens through the regulation of lipid-metabolism-related genes and transcription factor expression, J. Agric. Food Chem. 61 (2013) 8565-8572. https://doi.org/10.1021/jf402004x

[22]

D.P. Singh, J. Singh, R.K. Boparai, et al., Isomalto-oligosaccharides, a prebiotic, functionally augment green tea effects against high fat diet-induced metabolic alterations via preventing gut dysbacteriosis in mice, Pharmacol. Res. 123 (2017) 103-113. https://doi.org/10.1016/j.phrs.2017.06.015

[23]

D.B. Seo, H.W. Jeong, D. Cho, et al., Fermented green tea extract alleviates obesity and related complications and alters gut microbiota composition in diet-induced obese mice, J. Med. Food. 18 (2015) 549-556. https://doi.org/10.1089/jmf.2014.3265

[24]

M. Bose, J.D. Lambert, J. Ju, et al., The major green tea polyphenol, (–)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat fed mice, J. Nutr. 138 (2008) 1677-1683. https://doi.org/10.1093/jn/138.9.1677

[25]

M.A. Potenza, F.L. Marasciulo, M. Tarquinio, et al., EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR, Am. J. Physiol. Metab. 292 (2007) E1378. https://doi.org/10.1152/ajpendo.00698.2006

[26]

D.G. Raederstorff, M.F. Schlachter, V. Elste, et al., Effect of EGCG on lipid absorption and plasma lipid levels in rats, J. Nutr. Biochem. 14 (2003) 326-332. https://doi.org/10.1016/S0955-2863(03)00054-8

[27]

M. Donà, I. Dell'Aica, F. Calabrese, et al., Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis, J. Immunol. 170 (2003) 4335-4341. https://doi.org/10.4049/jimmunol.170.8.4335

[28]

A. Dube, J.A. Nicolazzo, I. Larson, Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (−)-epigallocatechin gallate, Eur. J. Pharm. Sci. 41 (2010) 219-225. https://doi.org/10.1016/j.ejps.2010.06.010

[29]

O. Krupkova, S.J. Ferguson, K. Wuertz-Kozak, Stability of (−)-epigallocatechin gallate and its activity in liquid formulations and delivery systems, J. Nutr. Biochem. 37 (2016) 1-12. https://doi.org/10.1016/j.jnutbio.2016.01.002

[30]

W. Liang, L. Zhao, J. Zhang, et al., Colonization potential to reconstitute a microbe community in pseudo germ-free mice after fecal microbe transplant from equol producer, Front. Microbiol. 11 (2020) 1221. https://doi.org/10.3389/fmicb.2020.01221

[31]

S. Gong, T. Lan, L. Zeng, et al., Gut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice, J. Hepatol. 69 (2018) 51-59. https://doi.org/10.1016/j.jhep.2018.02.024

[32]

T.Y. Reuter, Diet-induced models for obesity and type 2 diabetes, Drug Discov. Today Dis. Model. 4 (2007) 3-8. https://doi.org/10.1016/j.ddmod.2007.09.004

[33]

S. Lin, T.C. Thomas, L.H. Storlien, et al., Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice, Int. J. Obes. 24 (2000) 639-646. https://doi.org/10.1038/sj.ijo.0801209

[34]

F. Bäckhed, J.K. Manchester, C.F. Semenkovich, et al., Mechanisms underlying the resistance to diet-induced obesity in germ-free mice, Proc. Natl. Acad. Sci. 104 (2007) 979-984 https://doi.org/10.1073/pnas.0605374104

[35]

E. Bezirtzoglou, A. Tsiotsias, G.W. Welling, Microbiota profile in feces of breast-and formula-fed newborns by using fluorescence in situ hybridization (FISH), Anaerobe 17 (2011) 478-482. https://doi.org/10.1016/j.anaerobe.2011.03.009

[36]

P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, et al., An obesity-associated gut microbiome with increased capacity for energy harvest, Nature 444 (2006) 1027-1031. https://doi.org/10.1038/nature05414

[37]

P.D. Cani, L. Geurts, S. Matamoros, et al., Glucose metabolism: focus on gut microbiota, the endocannabinoid system and beyond, Diabetes Metab. 40 (2014) 246-257. https://doi.org/10.1016/j.diabet.2014.02.004

[38]

J. Walkowiak, J. Bajerska, A. Kargulewicz, et al., Single dose of green tea extract decreases lipid digestion and absorption from a test meal in humans, Acta Biochim. Pol. 60 (2013) 481-483

[39]

X. Wu, W. He, L. Yao, et al., Characterization of binding interactions of (−)-epigallocatechin-3-gallate from green tea and lipase, J. Agric. Food Chem. 61 (2013) 8829-8835. https://doi.org/10.1021/jf401779z

[40]

Z.J. Xu, J.G. Fan, X.D. Ding, et al., Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats, Dig. Dis. Sci. 55 (2010) 931-940. https://doi.org/10.1007/s10620-009-0815-3

[41]

D. Porras, E. Nistal, S. Martínez-Flórez, et al., Functional interactions between gut microbiota transplantation, quercetin, and high-fat diet determine non-alcoholic fatty liver disease development in germ-free mice, Mol. Nutr. Food Res. 63 (2019) 1800930. https://doi.org/10.1002/mnfr.201800930

[42]

M. Feuerer, L. Herrero, D. Cipolletta, et al., Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters, Nat. Med. 15 (2009) 930-939. https://doi.org/10.1038/nm.2002

[43]

A. Iljazovic, L. Amend, E.J.C. Galvez, et al., Modulation of inflammatory responses by gastrointestinal Prevotella spp. from associations to functional studies, Int. J. Med. Microbiol. 311 (2021) 151472. https://doi.org/10.1016/j.ijmm.2021.151472

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 24 April 2021
Revised: 06 October 2021
Accepted: 08 October 2021
Published: 04 February 2022
Issue date: May 2022

Copyright

© 2022 Beijing Academy of Food Sciences.

Acknowledgements

Acknowledgement

The work was financially support by the Key-Area Research and Development Program of Guangdong Province (2020B020226008, 2018b020206001), the National Science Foundation of China (NSFC31171673).

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return